TARGETED INHIBITION USING ENGINEERED OLIGONUCLEOTIDES

Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.

Saved in:
Bibliographic Details
Main Authors WILLIAMS, Tishan, SALEH, Anthony, PLACE, Robert
Format Patent
LanguageEnglish
Published 02.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
AbstractList Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
Author PLACE, Robert
SALEH, Anthony
WILLIAMS, Tishan
Author_xml – fullname: WILLIAMS, Tishan
– fullname: SALEH, Anthony
– fullname: PLACE, Robert
BookMark eNrjYmDJy89L5WQwDXEMcncNcXVR8PTz8HTyDPH091MIDfb0c1dw9XP39HN1DQLK-ft4uvv7hTr7uPqHeLq4BvMwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDIxNDE0NjEzNHQ2PiVAEAslMqlg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2024141346A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2024141346A13
IEDL.DBID EVB
IngestDate Fri Oct 11 05:32:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2024141346A13
Notes Application Number: US202318455756
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&CC=US&NR=2024141346A1
ParticipantIDs epo_espacenet_US2024141346A1
PublicationCentury 2000
PublicationDate 20240502
PublicationDateYYYYMMDD 2024-05-02
PublicationDate_xml – month: 05
  year: 2024
  text: 20240502
  day: 02
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies miRecule, Inc
RelatedCompanies_xml – name: miRecule, Inc
Score 3.5345283
Snippet Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title TARGETED INHIBITION USING ENGINEERED OLIGONUCLEOTIDES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&locale=&CC=US&NR=2024141346A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRJaDkFuxjk7KHIE2yaSNtUtpEeivdR0GQtNiIf9_JkmpPve3uwOwDZr799jED8CxVm0oqqNV1FBKUnhDWknNpLSlHMFkh59DXBePYGWbkbW7Pa_C5-wuj44T-6OCIaFEC7b3Q_nrzf4gV6LeV2xf-gU3r1zB1A7NixwhPdqtjBp7LJkmQ-Kbvu9nMjKda1kaHTZw-cqUj3Ej3Sntg7175L2WzDyrhORxPUF9eXEBN5Q049Xe51xpwMq6uvLFYWd_2Euy0Px0wdDVGFA8jLypPl4wyb8bA2MWHQlkyigZJnPkjlqRRwGZX8BSy1B9a2P_ib7qLbLY_2O411PN1rm7AkD2kE9TmHaoUIUIuEeulkF1B25y0OLmF5iFNd4fF93BWVvVjvk4T6sXXt3pAwC34o16nX_aXfwo
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFeubVsWjakDJW7BH0rAPRdrcmqO0ifStdA9BkLTYiH_fyZJon_q27MDsATPffjO7swCPXPQIJ4xog6FAgmIypq0o5dqKUASTd-QcMl0QxUM_018WxqIBn_VbGFkn9EcWR0SLYmjvhfTXm_8gli3vVm6f6Ad2rZ_ddGSrFTtGeDK6fdWejJxpYieWalmjbK7GMynrocPWh2PkSgd4yDZLe3DeJuW7lM0uqLgncDhFfXlxCg2Rt6Fl1X-vteEoqlLe2Kysb3sGRjqeeQ66GiWI_WASlNElpfw3w1Pq-lAoS8LAS-LMCp0kDWxnfg4PrpNavobjL_-Wu8zmu5MdXEAzX-fiEhRuIp0gBu0TIXSd8RViPWd8wEiP6l2qX0Fnn6br_eJ7aPlpFC7DIH69geNSJC_29TvQLL6-xS2Cb0Hv5J79Ahd6gf0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TARGETED+INHIBITION+USING+ENGINEERED+OLIGONUCLEOTIDES&rft.inventor=WILLIAMS%2C+Tishan&rft.inventor=SALEH%2C+Anthony&rft.inventor=PLACE%2C+Robert&rft.date=2024-05-02&rft.externalDBID=A1&rft.externalDocID=US2024141346A1